OUR COMPANY

Key dates

  • 1

    1970

    Creation of the Nuclear Medicine department at the new Brabois hospital (Prof. A. Bertrand)

  • 2

    2001

    Installation of the first PET-Scan in a university hospital (CHRU) and the production cyclotron at the Brabois site

  • 3

    2007

    Creation of the Nancyclotep economic interest group (GIE)

  • 4

    2008

    Commissioning of the second PET-Scan at the CHRU (funded and operated by Nancyclotep)

  • 5

    2015

    "FILODIM" project funded by the Lorraine Region enabling the acquisition of a PET-Scan

  • 6

    2018

    Grant of €7.2M obtained through the European Regional Development Fund (FIGEDIM project) to make the CHRU of Nancy a reference site for clinical research and care in Nuclear Medicine and Targeted Internal Radiotherapy, with the support of the Regional Health Agency (ARS)

  • 7

    2019

    Official launch of the RTIV project in the presence of the President of the French National Authority for Health

  • 8

    2020

    Opening of the radiopharmaceutical production laboratory by Posifit

  • 9

    2022

    Progressive commissioning of the R&D and production platform at the Brabois site

  • 10

    2023

    Acquisition of an additional PET-Scan by Nancyclotep

  • 11

    2024

    Design of the industrial project "PROTHERIUM"